Page last updated: 2024-09-03

rasagiline and Aging

rasagiline has been researched along with Aging in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amit, T; Badinter, F; Bar-Am, O; Weinreb, O; Youdim, MB1
Cohen, S; Dror, V; Eliash, S; Rehavi, M1
Chen, JJ; Fernandez, HH1
Cohen, S; Levy, R; Speiser, Z1
Maruyama, W; Naoi, M1
Carrillo, MC; Ivy, GO; Kanai, S; Kitani, K; Maruyama, W; Minami, C; Yamamoto, T1

Reviews

2 review(s) available for rasagiline and Aging

ArticleYear
Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors.
    Drugs & aging, 2007, Volume: 24, Issue:8

    Topics: Aged; Aging; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Homes for the Aged; Humans; Indans; Levodopa; Monoamine Oxidase Inhibitors; Nursing Homes; Parkinson Disease; Selegiline

2007
Do antioxidant strategies work against aging and age-associated disorders? Propargylamines: a possible antioxidant strategy.
    Annals of the New York Academy of Sciences, 2001, Volume: 928

    Topics: Aging; Alkynes; Animals; Antioxidants; Brain; Brain Chemistry; Catalase; Corpus Striatum; Cricetinae; Dogs; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Induction; Female; Free Radicals; Heart; Humans; Indans; Kidney; Longevity; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Neuroprotective Agents; Organ Specificity; Rats; Rats, Inbred F344; Selegiline; Superoxide Dismutase

2001

Other Studies

4 other study(ies) available for rasagiline and Aging

ArticleYear
Effect of long-term treatment with rasagiline on cognitive deficits and related molecular cascades in aged mice.
    Neurobiology of aging, 2015, Volume: 36, Issue:9

    Topics: Aging; Animals; Catecholamines; Cognition Disorders; Corpus Striatum; Disease Models, Animal; Exploratory Behavior; Gene Expression Regulation; Indans; Longitudinal Studies; Male; Maze Learning; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Neuroprotective Agents; Receptors, Dopamine D1; Receptors, Dopamine D2; Signal Transduction; Swimming

2015
Neuroprotection by rasagiline in thiamine deficient rats.
    Brain research, 2009, Feb-23, Volume: 1256

    Topics: Aging; Analysis of Variance; Animals; Behavior, Animal; Brain; Disease Models, Animal; Indans; Kaplan-Meier Estimate; Male; Maze Learning; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nerve Degeneration; Neuroprotective Agents; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Selegiline; Thiamine Deficiency

2009
Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders.
    Journal of neural transmission. Supplementum, 1998, Volume: 52

    Topics: Aging; alpha-Methyltyrosine; Animals; Avoidance Learning; Catalepsy; Cognition; Cognition Disorders; Haloperidol; Hypokinesia; Hypoxia; Indans; Male; Memory; Mice; Mice, Inbred ICR; Monoamine Oxidase Inhibitors; Motor Activity; Rats; Rats, Wistar

1998
Neuroprotection by (-)-deprenyl and related compounds.
    Mechanisms of ageing and development, 1999, Volume: 111, Issue:2-3

    Topics: Aging; Amphetamines; Animals; Antioxidants; Apoptosis; Cattle; DNA Damage; DNA, Neoplasm; Indans; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Nitrates; Oxidants; Parkinson Disease; Selegiline; Tumor Cells, Cultured

1999